NLRP3 and atherosclerosis: In addition, Metformin was shown to inhibit NLRP3 inflammasome activation, and suppressed atherosclerosis in ApoE−/− mice, at least partially through activation of AMPK and regulation of Trx-1/TxNIP [226].